AMBROSE Cell Therapy
Setting a new standard of safety and care for patients with complex chronic degenerative diseases.
Setting a new standard of safety and care for patients with complex chronic degenerative diseases.
AMBROSE Cell Therapy is a biotechnology and healthcare startup founded in 2018 with the slogan "Setting a new standard of safety and care for patients with complex chronic degenerative diseases." Based near Dallas, Texas, they comply with House Bill 810, offering patients right-to-try experimental stem cell treatments using adipose-derived stem and regenerative cells (ADRCs) to improve symptoms, function, and quality of life. Their approach is personalized for each patient, with cell therapy performed in a same-day, single outpatient procedure. The treatment includes tissue harvesting, cell preparation, and a unique cell delivery strategy developed based on the patient’s goals. For more information about AMBROSE, treatment candidacy, or becoming a patient, visit www.ambrosecelltherapy.com.
There is no investment information
No recent news or press coverage available for AMBROSE Cell Therapy.
We care about your data, and we'd love to use cookies make your experience better.
